{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:27:50Z","timestamp":1770902870144,"version":"3.50.1"},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T00:00:00Z","timestamp":1408665600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s10620-014-3323-z","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T08:21:07Z","timestamp":1408609267000},"page":"2602-2603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Infliximab Leading to Autoimmune Hepatitis: An Increasingly Recognized Side Effect"],"prefix":"10.1007","volume":"59","author":[{"given":"Bulent","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emir Charles","family":"Roach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyfettin","family":"Koklu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,22]]},"reference":[{"key":"3323_CR1","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1007\/s10620-013-2698-6","volume":"58","author":"F Colina","year":"2013","unstructured":"Colina F, Molero A, Cas\u00eds B, Mart\u00ednez-Montiel P. Infliximab-related hepatitis: a case study and literature review. Dig Dis Sci. 2013;58:3362\u20133367.","journal-title":"Dig Dis Sci"},{"key":"3323_CR2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.5694\/j.1326-5377.2007.tb01396.x","volume":"187","author":"G Ozorio","year":"2007","unstructured":"Ozorio G, McGarity B, Bak H, et al. Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis. Med J Aust. 2007;187:524\u2013526.","journal-title":"Med J Aust"},{"key":"3323_CR3","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1007\/s10620-011-1748-1","volume":"56","author":"DA Goldfeld","year":"2011","unstructured":"Goldfeld DA, Verna EC, Lefkowitch J. Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn\u2019s disease: the index case. Dig Dis Sci. 2011;56:3386\u20133388.","journal-title":"Dig Dis Sci"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-014-3323-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-014-3323-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-014-3323-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T14:54:50Z","timestamp":1598194490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-014-3323-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,22]]},"references-count":3,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["3323"],"URL":"https:\/\/doi.org\/10.1007\/s10620-014-3323-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,22]]}}}